Professor of Medicine in Cardiology and Population Health Science and Policy, Mount Sinai Professor in Cardiovascular Clinical Research and Outcomes, Director of Interventional Cardiovascular Research and Clinical Trials
Icahn School of Medicine at Mount Sinai, NY
New York City, New York, United States
Roxana Mehran, MD, FACC, FACP, FCCP, FESC, FAHA, MSCAI; Mount Sinai Professor in Cardiovascular Clinical Research and Outcomes; Professor of Medicine (Cardiology) and Population Health Science and Policy at the Icahn School of Medicine at Mount Sinai is an internationally renowned interventional cardiologist, and clinical research expert in the field of cardiovascular disease. She has built a globally-respected academic research center focused on developing randomized clinical trials and has served as principal investigator for numerous global studies, developed risk scores for bleeding and acute kidney injury, participates regularly in developing clinical guidelines, and has authored >1,000 peer-reviewed articles. Dr Mehran is a current member of the American College of Cardiology (ACC) Board of Trustees and is a founder and Chief Scientific Officer of the Cardiovascular Research Foundation (CRF). She has been included for three consecutive years in Clarivate Analytics: “Most Cited Researchers – Top 1%”. In 2019, she founded Women as One, dedicated to advancing opportunities for women in medicine.
Dr Mehran is currently leading the Lancet Commission on Women’s Cardiovascular Diseases, which brings together leading female researchers from around the world to identify and bridge gaps in research and care for women with cardiovascular disease.
Dr Mehran is a recipient of several awards including the 2016 American College of Cardiology Bernadine Healy Leadership in CV disease award, the 2018 Nanette Wenger Award from Women’s Heart for excellence in research and education, the 2019 Ellis Island Medal of Honor, and the 2019 ESC Silver Medal and Andreas Grüntzig Lecture plaque.
Abbott: paid to the institution, Research Grant or Support
Abiomed: funding paid to institution, Research Grant or Support
ACC (BOT Member): Advisory Board
Alleviant: funding paid to institution, Research Grant or Support
AMA: Advisory Board
AM-Pharma: funding paid to institution, Research Grant or Support
Applied Therapeutics: Equity, funding paid to institution, Research Grant or Support, Stockholder
Arena: funding paid to institution, Research Grant or Support
AstraZeneca: funding paid to institution, Research Grant or Support
Bayer: funding paid to institution, Research Grant or Support
Biosensors: funding paid to institution, Research Grant or Support
Biosensors (spouse): Advisory Board
Biotronik: funding paid to institution, Research Grant or Support
BMS: funding paid to institution, Research Grant or Support
Boston Scientific: Consultant; BSC: funding paid to institution, Research Grant or Support
CardiaWave: funding paid to institution, Research Grant or Support
CellAegis: funding paid to institution, Research Grant or Support
CeloNova: funding paid to institution, Research Grant or Support
Chiesi: funding paid to institution, Research Grant or Support
Cine-Med Research: Consultant
CIRM: Consultant
Concept Medical: funding paid to institution, Research Grant or Support
ControlRad (spouse): Equity, Stockholder
CSL Behring: funding paid to institution, Research Grant or Support
DSI: funding paid to institution, Research Grant or Support
Duke University: funding paid to institution, Research Grant or Support
Elixir Medical: Equity, Stockholder
Humacyte: funding paid to institution, Research Grant or Support
Idorsia Pharmaceuticals: CONSULTING FEES PAID TO INSTITUTION, Research Grant or Support
Insel Gruppe AG: funding paid to institution, Research Grant or Support
Janssen: Consultant, funding paid to institution, Research Grant or Support
Medtronic: CONSULTING FEES PAID TO INSTITUTION, funding paid to institution, Research Grant or Support, Research Grant or Support
Novartis: CONSULTING FEES PAID TO INSTITUTION, Research Grant or Support
OrbusNeich: funding paid to institution, Research Grant or Support
Philips: CONSULTING FEES PAID TO INSTITUTION, Research Grant or Support, Research Grant or Support
SCAI: Consultant
STEL: Equity, Stockholder
Vivasure: funding paid to institution, Research Grant or Support
WebMD: Consultant
Zoll: funding paid to institution, Research Grant or Support